Research Article

The Effectiveness of Anti-R. equi Hyperimmune Plasma against R. equi Challenge in Thoroughbred Arabian Foals of Mares Vaccinated with R. equi Vaccine

Table 6

Complete blood count and blood gas analysis results of foals.

Foal groupDay 0Day 1Day 5Day 10Day 14Day 20Day 30

pH (7.34–7.43)Control7.45 ± 0.027.41 ± 0.027.43 ± 0.027.35 ± 0.037.42 ± 0.017.45 ± 0.027.40 ± 0.02
Vaccinated7.43 ± 0.017.42 ± 0.017.41 ± 0.017.41 ± 0.017.41 ± 0.017.39 ± 0.017.42 ± 0.01

pCO2 (38–48 mmHg)Control37.50 ± 1.1942.25 ± 0.7545.75 ± 1.9352.75 ± 2.78 A47.33 ± 2.7340.50 ± 1.5047.00 ± 3.00
Vaccinated40.00 ± 1.7842.00 ± 1.4742.00 ± 0.4140.25 ± 125 B42.00 ± 2.7445.00 ± 3.1440.50 ± 1.26

pO2 (37–56 mmHg)Control35.00 ± 2.1235.00 ± 2.1236.75 ± 1.55 A33.00 ± 1.3532.00 ± 2.0838.00 ± 4.0034.00 ± 1.01 B
Vaccinated37.25 ± 3.7133.50 ± 2.6329.00 ± 1.91 B36.25 ± 1.7553.75 ± 21.4633.75 ± 2.2941.25 ± 1.38A

tCO2Control26.98 ± 1.2628.03 ± 1.2131.53 ± 1.8130.53 ± 0.61 A31.87 ± 1.1829.05 ± 0.5530.20 ± 0.90
Vaccinated27.85 ± 0.4528.35 ± 0.7328.05 ± 0.2926.75 ± 0.84 B27.95 ± 1.4754.15 ± 27.3027.65 ± 0.57

SO2 (>60 mmHg)Control70.00 ± 2.4867.00 ± 3.3771.50 ± 1.32 A71.50 ± 1.32 A62.67 ± 4.6774.50 ± 4.5065.00 ± 1.00 B
Vaccinated71.25 ± 6.7064.75 ± 4.8755.50 ± 4.29 B55.50 ± 4.29 B71.50 ± 9.5053.90 ± 7.4277.75 ± 1.38 A

WBC (5–12 ×  )Control7.08 ± 1.017.68 ± 1.317.32 ± 1.167.02 ± 1.125.65 ± 1.664.64 ± 0.3710.53 ± 2.61
Vaccinated6.66 ± 0.875.86 ± 0.338.82 ± 1.298.86 ± 0.878.60 ± 0.6626.90 ± 15.7710.33 ± 1.57

LYM (% 20–40)Control15.60 ± 2.46 B15.70 ± 0.90 B22.65 ± 2.4122.80 ± 1.86 B29.13 ± 11.5236.85 ± 14.7517.50 ± 10.00
Vaccinated35.60 ± 3.98 A30.65 ± 2.23 A34.63 ± 6.4336.75 ± 4.88 A37.83 ± 4.2627.11 ± 6.5131.85 ± 3.40

MON (% 2–8)Control1.40 ± 0.12 B1.68 ± 0.113.55 ± 0.133.43 ± 0.773.67 ± 1.223.50 ± 0.901.60 ± 0.70 A
Vaccinated2.75 ± 0.45 A2.73 ± 0.523.00 ± 0.483.05 ± 0.463.58 ± 0.338.00 ± 5.902.53 ± 0.46

GRAN (% 50–70)Control83.00 ± 2.55 A82.63 ± 0.92 A73.80 ± 2.4673.78 ± 2.3267.20 ± 12.7259.65 ± 15.6580.90 ± 10.70
Vaccinated61.65 ± 3.70 B64.75 ± 4.87 B62.38 ± 6.6960.20 ± 5.1058.60 ± 4.4249.43 ± 16.3565.63 ± 3.78

RBC (7–13 ×  )Control8.87 ± 0.489.28 ± 0.899.27 ± 0.399.10 ± 0.718.10 ± 0.64 B9.01 ± 1.168.05 ± 0.24 B
Vaccinated9.65 ± 0.3211.30 ± 1.0210.22 ± 0.3410.03 ± 0.229.89 ± 0.26 A25.16 ± 15.829.98 ± 0.27 A

MCV (35–60 fl)Control32.63 ± 0.29 A32.83 ± 0.24 A32.78 ± 0.71 A34.48 ± 0.47 A33.23 ± 0.9132.70 ± 0.9032.00 ± 1.90
Vaccinated29.43 ± 1.14 B29.95 ± 0.76 B29.50 ± 0.93 B29.30 ± 0.99 B30.85 ± 0.9226.24 ± 5.4330.50 ± 0.68

HCT (% 32–53)Control28.85 ± 1.3930.43 ± 3.0430.30 ± 1.1031.38 ± 2.6626.77 ± 1.3929.30 ± 3.0025.65 ± 0.75 B
Vaccinated28.43 ± 1.9833.70 ± 2.9030.10 ± 1.1129.35 ± 1.4230.43 ± 0.9229.18 ± 0.7130.33 ± 0.50 A

MCHC (30–42 g/dL)Control39.75 ± 0.4336.18 ± 2.5039.63 ± 0.2636.78 ± 0.8637.43 ± 0.4538.85 ± 0.1540.50 ± 1.20
Vaccinated39.50 ± 1.6740.60 ± 0.9443.65 ± 3.0741.73 ± 1.1537.93 ± 0.6138.40 ± 0.9338.70 ± 1.09

RDW (8–12)Control14.45 ± 0.1014.60 ± 0.47 B14.30 ± 0.27 B14.10 ± 0.43 B14.13 ± 0.2915.05 ± 0.8516.65 ± 0.65
Vaccinated15.40 ± 0.5416.00 ± 0.31 A15.85 ± 0.37 A16.18 ± 0.55 A16.30 ± 0.8316.70 ± 1.0017.15 ± 0.84

HB (11–17 g/dL)Control11.48 ± 0.4710.83 ± 0.5912.03 ± 0.5111.53 ± 0.8610.03 ± 0.6411.40 ± 1.2010.40 ± 0.00
Vaccinated11.18 ± 0.5513.68 ± 1.1212.40 ± 0.4412.23 ± 0.4311.55 ± 0.3911.23 ± 0.4411.75 ± 0.48

THR (100–400 m/mm3)Control278.50 ± 87.36330.50 ± 87.36287.00 ± 44.53238.50 ± 29.83 B171.33 ± 30.69240.00 ± 37.00241.50 ± 8.50
Vaccinated248.50 ± 30.01317.00 ± 40.26410.00 ± 49.83384.50 ± 9.56 A244.00 ± 19.20341.50 ± 26.38279.00 ± 25.65